Suvretta Capital Management, LLC Prelude Therapeutics Inc Transaction History

Suvretta Capital Management, LLC

  • $2.4 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$39.27 - $91.68 $4.36 Million - $10.2 Million
-111,065 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$28.81 - $88.94 $3.28 Million - $10.1 Million
-113,935 Reduced 50.64%
111,065 $7.95 Million
Q3 2020

Nov 16, 2020
BUY
$26.2 - $30.13 $5.9 Million - $6.78 Million
225,000 New
225,000 $6.78 Million

Others Institutions Holding PRLD

# of Institutions
66
Shares Held
36M
Call Options Held
500
Put Options Held
300
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $35.3M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email